Home › Medivation: A Beaten Down Biotech With Major Growth Potential
 

Keywords :   


Medivation: A Beaten Down Biotech With Major Growth Potential

2015-09-21 19:51:31| Biotech - Topix.net

Note: The prices discussed in the article below reflects the recent 2-for-1 split in the stock price, effective September 16, 2015. Medivation is a commercial and developmental stage biotech company focused on developing treatments for severe, un-met indications.

Tags: major potential growth biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Public Advisory Number 20A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Genesus to restructure with Canada ZF Investments
03.07Global trade, domestic policy: What's at stake for pork industry
03.07Over 20,000 Tesco staff to split 30m from share schemes
03.07Ex-Post Office chair denies hiding key Horizon report
More »